Real-time enrollment status for this mantle cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 3:13 AM UTC
| NCT Number | NCT06029309 |
| Recruiting Status | Recruiting |
| Condition | Mantle Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Alvaro Alencar, MD |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT06029309 is currently recruiting participants. This phase1 study for mantle cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Alvaro Alencar, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06029309 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06029309 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.